Adagio Medical Advances vCLAS Ultra in Ventricular Tachycardia
LAGUNA HILLS, Calif. — September 16, 2026 Adagio Medical Holdings, Inc. announced the first patient enrollment in its FDA-approved...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LAGUNA HILLS, Calif. — September 16, 2026 Adagio Medical Holdings, Inc. announced the first patient enrollment in its FDA-approved...
JACKSONVILLE, Fla., July 30, 2026 Medical Microinstruments (MMI) announced that the U.S. Food and Drug Administration (FDA) has approved...
KENNEWICK, Wash., July 6, 2026 Vivos Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the...
MINNEAPOLIS & BRISBANE, May 13, 2025—Anteris Technologies Global Corp. announced its first-quarter 2025 results, revealing significant progress across clinical...
TORINO, Italy – October 2, 2025 – AorticLab has achieved a major milestone with the U.S. Food and Drug...
